Trials / Completed
CompletedNCT04527770
Midazolam Versus Dexamethasone as an Adjuvant to Local Anesthetics in the Ultrasound Guided Hydrodissection of Median Nerve for Treatment of Carpal Tunnel Syndrome Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 134 (actual)
- Sponsor
- Minia University · Academic / Other
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
midazolam and dexamethasone both can counteract chronic pain. either via GABA mimetic action or via anti prostaglandins
Detailed description
Entrapement syndrome - namely median nerve compression in carpal tunnel syndrome - causes chronic pain that can be refractory to medical treatment . Ultrasound guided hydrodissection is an option for alleviating pain . Recurrence is the main side effect of injection. We try in this research to prevent recurrence rate . Midazolam and dexamethasone both are used in chronic pain . Midazolm act by GABA mimetic action while dexamethasone act by decrease interleukin formation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone | Ultrasound guided median nerve hydrodiseection using dexamethasone or midazolam |
| DRUG | Midazolam injection | intracarpal injection of midazolam and bupivacaine 0.5% |
Timeline
- Start date
- 2020-09-01
- Primary completion
- 2021-03-01
- Completion
- 2021-04-30
- First posted
- 2020-08-27
- Last updated
- 2022-02-18
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04527770. Inclusion in this directory is not an endorsement.